Journal rackBMJ 2003; 327 doi: https://doi.org/10.1136/bmjusa.02050003 (Published 19 November 2003) Cite this as: BMJ 2003;327:E111
This article originally appeared in BMJ USA
This section calls attention to new studies and systematic reviews, selected by the Editor from journals published just as this issue went into production (approximately 2 months before publication). The Journals hand-searched for the Journal Rack are: American Journal of Medicine, American Journal of Preventive Medicine, Annals of Internal Medicine, Circulation, JAMA, Journal of Family Practice, Journal of General Internal Medicine, Journal of the American Board of Family Practice, JNCI, Lancet, New England Journal of Medicine, and Pediatrics. Studies are noted that might directly influence clinical practice decisions in primary care and have been classified by type of problem addressed.
Cardiovascular—A randomized trial involving 9193 patients with essential hypertension and left ventricular hypertrophy compared the effects of losartan, a selective angiotensin-II receptor antagonist, and atenolol over 4 years. Although both groups experienced similar blood pressure reductions, the losartan group had a lower risk of cardiovascular events and death. Losartan appeared to achieve benefits beyond blood pressure reduction (Dahlöf et al. Lancet March 23 2002;359:995–1003).
Cardiovascular—An analysis of 388,964 admissions to New York hospitals for heart failure, myocardial infarction, or stroke in 1993–1995 found that standardized …
Log in using your username and password
Log in through your institution
Sign up for a free trial